Mark S. Levine - 19 Jul 2021 Form 4 Insider Report for Flexion Therapeutics Inc

Role
General Counsel
Signature
/s/ Mark S. Levine
Issuer symbol
N/A
Transactions as of
19 Jul 2021
Net transactions value
-$25,445
Form type
4
Filing time
20 Jul 2021, 20:45:42 UTC
Next filing
19 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLXN Common Stock Sale $25,445 -3,945 -2.9% $6.45 133,486 19 Jul 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares of common stock to cover tax withholding obligations associated with the vesting of restricted stock unit award granted to the Reporting Person on July 16, 2020.
F2 The weighted average sale price for the transaction reported was $6.45. The shares were sold at a range of prices between $6.24 and $6.46. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.